TCL Archive GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL July 26, 2013
TCL Archive In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center August 1, 1997
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Review Of Cancer Center supports Grants Needs Refocus On Science, Advisors Say October 18, 1996
